"我这么瘦，怎么会患妊娠期糖尿病？""我只是血糖高一点，生完孩子就好了，应该没什么关系 吧？"……在妇产科，准妈妈们类似的问题几乎每天都能听到。随着生活方式的改变和诊断标准的更 新，妊娠期糖尿病已成为我国孕期最常见的并发症之一。本文旨在澄清公众对妊娠期糖尿病的常见误 区，提供科学、实用的知识，帮助准妈妈们正确认识、积极应对这一"甜蜜的负担"。 我国妊娠期糖尿病发病率仍在上升 最新的流行病学数据显示，我国妊娠期糖尿病发病率高达17.5%，相当于每6位孕妇中就有1位面临这一 问题。随着二孩、三孩政策的开放和高龄孕妇比例的增加，这一数字仍在上升。 然而，公众对妊娠期糖尿病的认知却存在显著不足与误区。许多准妈妈要么过度焦虑，要么不当回事， 这两种态度都可能对母婴健康造成不利影响。 妊娠期糖尿病，是指妊娠期间首次发生或发现的不同程度的糖代谢异常。这主要由于妊娠期胎盘分泌的 激素（如孕激素、雌激素）会对抗胰岛素的作用，导致胰岛素抵抗增加。当孕妇的胰岛功能无法代偿这 种抵抗时，血糖就会升高。 绝大多数妊娠期糖尿病发生在孕24～28周，且多数在产后能恢复正常。但它显著增加未来患2型糖尿病 的风险。因此，糖尿病筛查对孕妇来说非 ...

Core Viewpoint - The article highlights the alarming rise in global diabetes prevalence, with over 800 million adults affected, and emphasizes the urgent need for improved public health strategies and early intervention, particularly in high-risk populations like China [5][9][10]. Group 1: Global Diabetes Trends - The total number of global adult diabetes patients has surpassed 800 million, a fourfold increase since 1990, with 4.45 million untreated patients aged 30 and above in 2022 [5][9]. - By 2050, global diabetes patients are projected to exceed 1.31 billion, indicating a significant public health challenge ahead [7]. - The global diabetes prevalence rate increased by 90.5% from 1990 to 2021, rising from 3.2% to 6.1% [7]. Group 2: Diabetes in China - China has 148 million diabetes patients, ranking second globally, with over 52% of these patients untreated [9][10]. - The majority of new diabetes cases in China are type 2 diabetes, accounting for 99.2% of new cases in 2021 [10]. - The gender disparity in diabetes-related health burdens is notable, with men experiencing a higher disability burden compared to women [10]. Group 3: Complications and Healthcare Burden - Approximately 30% to 40% of diabetes patients may develop chronic kidney disease (CKD), with type 2 diabetes being a major contributing factor [8]. - The number of new CKD cases due to type 2 diabetes rose from 1.4 million in 1990 to 2.4 million in 2017, a 74% increase [8]. - The treatment resources for end-stage kidney disease (ESKD) are unevenly distributed globally, with only 27% to 53% of patients receiving necessary care [8]. Group 4: Prevention and Control Strategies - The updated "China Diabetes Prevention and Control Guidelines (2024)" indicates a continuous rise in diabetes prevalence, necessitating enhanced screening and diagnostic measures [11][12]. - The national health initiative aims to increase diabetes awareness and screening rates, targeting a 60% awareness rate among adults by 2030 [12][13]. - The guidelines emphasize the importance of regular blood sugar testing for high-risk groups and the need for improved healthcare capabilities at the grassroots level [12][13].